Mylan's Biggest Holder Set to Unload Shares
Billionaire financier Carl Icahn is about
to reclaim his crown as Mylan Laboratories'
largest shareholder. The current titleholder, hedge fund operator
disclosed recently that he intended to liquidate his 9.9 percent stake
Canonsburg generic drugmaker now that Mylan has canceled plans to
Pharmaceuticals. Perry purchased 26.6 million Mylan shares in order to
sure Mylan shareholders approved the King acquisition. Perry used
swap agreements to basically break even on his Mylan investment and
to make money when Mylan purchased King's shares.